Internal Medicine - Issue 4/2022
Editorial
Main Topic
208
COVID-19 and post-COVID – Jekyll and Hyde of modern medicine
Eliška Sovová, Samuel Genzor, Milan Sova, Markéta Sovová, Katarína Moravcová, Martin Šimek, Lenka Obare Pyzsková
212
217
Neo/adjuvant immunotherapy in the treatment of non‑small cell lung cancer
Martin Svatoň, Jiří Blažek, Marcela Burešová, Josef Vodička
Review Articles
221
Prevention and treatment of cancer associated venous thromboembolism – interdisciplinary consensus
Ivar Vacula, Zuzana Rusiňáková, Denisa Čelovská, Peter Jackuliak, Ján Slopovský, Patrik Palacka, Matej Moščovič, Stanislav Špánik, Ján Staško, Alexander Wild, Angelika Bátorová, Juraj Ma Arič
227
Acute kidney injury due to antimicrobial therapy
Viktor Klementa, Naděžda Petejová, Josef Zadražil, Pavel Horák, Jitka Prošková, Olga Klementová
234
240
Acetylsalicylic acid in primary prevention of cardiovascular disease
Roman Miklík, Otakar Jiravský
246
Had care of arterial hypertension patients been advanced in 2021?
Anna Vachulová, Adriana Šimková, Slavomíra Filipová
253
Internal Medicine
2022 Číslo 4
Najčítanejšie v tomto čísle
- Development of recommendations for the use of venoactive drugs in the treatment of chronic venous disease – where they are effective and where they are not
- Acetylsalicylic acid in primary prevention of cardiovascular disease
- Urapidil: an unknown / known antihypertensive
- Acute kidney injury due to antimicrobial therapy